Argus Downgrades Pfizer (PFE) to Hold, 'faces near-term headwinds to top-line growth'
Tweet Send to a Friend
(Updated - March 22, 2024 7:26 AM EDT)
Argus analyst David Toung downgraded Pfizer (NYSE: PFE) from Buy to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Argus analyst David Toung downgraded Pfizer (NYSE: PFE) from Buy to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
